BIOMAT Database Logo BIOMAT Database Logo

Identification of nuclear matrix protein alterations associated with renal cell carcinoma. 1998

B R Konety, and A K Nangia, and T S Nguyen, and B N Veitmeier, and R Dhir, and J S Acierno, and M J Becich, and R L Hrebinko, and R H Getzenberg
Department of Pathology, University of Pittsburgh Cancer Institute, University of Pittsburgh, Pennsylvania 15213, USA.

OBJECTIVE Neoplastic transformation, including renal cell carcinoma (RCC), is always accompanied by changes in nuclear morphology. Nuclear grading of RCC is based on characteristic alterations in nuclear shape, size, area and other morphologic parameters. The nuclear matrix, which forms the skeleton of the nucleus, determines nuclear morphology. Alterations in nuclear matrix protein (NMP) composition specific to tissue and cancer type have been described in a variety of human cancers. We conducted a study to analyze the nuclear matrix protein composition of renal cell carcinoma and compare it to that of normal renal tissue and renal cell carcinoma cells grown in culture. METHODS We analyzed the nuclear matrix protein composition of RCC tumor tissue and that of normal kidney tissue obtained from seventeen patients undergoing radical nephrectomy for RCC. We also analyzed the NMP composition of two renal cancer cell lines (A-498 and 769-P). RESULTS We were able to identify five different and unique NMPs which were present only in the human RCC tumor samples and were absent in all normal kidney tissue. One NMP was found specifically in the normal kidney tissue. All five RCC specific NMPs were also identified in the nuclear matrix of the two cell lines analyzed. CONCLUSIONS Five nuclear matrix proteins specific and unique to RCC were identified. These NMPs are different from those previously identified in other tissues and neoplasms. The RCC specific NMPs identified in this study can potentially be used as diagnostic markers for renal cell carcinoma and for therapeutic tumor targeting.

UI MeSH Term Description Entries
D007680 Kidney Neoplasms Tumors or cancers of the KIDNEY. Cancer of Kidney,Kidney Cancer,Renal Cancer,Cancer of the Kidney,Neoplasms, Kidney,Renal Neoplasms,Cancer, Kidney,Cancer, Renal,Cancers, Kidney,Cancers, Renal,Kidney Cancers,Kidney Neoplasm,Neoplasm, Kidney,Neoplasm, Renal,Neoplasms, Renal,Renal Cancers,Renal Neoplasm
D008297 Male Males
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D009687 Nuclear Proteins Proteins found in the nucleus of a cell. Do not confuse with NUCLEOPROTEINS which are proteins conjugated with nucleic acids, that are not necessarily present in the nucleus. Nucleolar Protein,Nucleolar Proteins,Nuclear Protein,Protein, Nuclear,Protein, Nucleolar,Proteins, Nuclear,Proteins, Nucleolar
D002292 Carcinoma, Renal Cell A heterogeneous group of sporadic or hereditary carcinoma derived from cells of the KIDNEYS. There are several subtypes including the clear cells, the papillary, the chromophobe, the collecting duct, the spindle cells (sarcomatoid), or mixed cell-type carcinoma. Adenocarcinoma, Renal Cell,Carcinoma, Hypernephroid,Grawitz Tumor,Hypernephroma,Renal Carcinoma,Adenocarcinoma Of Kidney,Adenocarcinoma, Renal,Chromophil Renal Cell Carcinoma,Chromophobe Renal Cell Carcinoma,Clear Cell Renal Carcinoma,Clear Cell Renal Cell Carcinoma,Collecting Duct Carcinoma,Collecting Duct Carcinoma (Kidney),Collecting Duct Carcinoma of the Kidney,Nephroid Carcinoma,Papillary Renal Cell Carcinoma,Renal Cell Cancer,Renal Cell Carcinoma,Renal Cell Carcinoma, Papillary,Renal Collecting Duct Carcinoma,Sarcomatoid Renal Cell Carcinoma,Adenocarcinoma Of Kidneys,Adenocarcinomas, Renal Cell,Cancer, Renal Cell,Carcinoma, Collecting Duct,Carcinoma, Collecting Duct (Kidney),Carcinoma, Nephroid,Carcinoma, Renal,Carcinomas, Collecting Duct,Carcinomas, Collecting Duct (Kidney),Carcinomas, Renal Cell,Collecting Duct Carcinomas,Collecting Duct Carcinomas (Kidney),Hypernephroid Carcinoma,Hypernephroid Carcinomas,Hypernephromas,Kidney, Adenocarcinoma Of,Nephroid Carcinomas,Renal Adenocarcinoma,Renal Adenocarcinomas,Renal Carcinomas,Renal Cell Adenocarcinoma,Renal Cell Adenocarcinomas,Renal Cell Cancers,Renal Cell Carcinomas,Tumor, Grawitz
D005260 Female Females
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000368 Aged A person 65 years of age or older. For a person older than 79 years, AGED, 80 AND OVER is available. Elderly
D015415 Biomarkers Measurable and quantifiable biological parameters (e.g., specific enzyme concentration, specific hormone concentration, specific gene phenotype distribution in a population, presence of biological substances) which serve as indices for health- and physiology-related assessments, such as disease risk, psychiatric disorders, ENVIRONMENTAL EXPOSURE and its effects, disease diagnosis; METABOLIC PROCESSES; SUBSTANCE ABUSE; PREGNANCY; cell line development; EPIDEMIOLOGIC STUDIES; etc. Biochemical Markers,Biological Markers,Biomarker,Clinical Markers,Immunologic Markers,Laboratory Markers,Markers, Biochemical,Markers, Biological,Markers, Clinical,Markers, Immunologic,Markers, Laboratory,Markers, Serum,Markers, Surrogate,Markers, Viral,Serum Markers,Surrogate Markers,Viral Markers,Biochemical Marker,Biologic Marker,Biologic Markers,Clinical Marker,Immune Marker,Immune Markers,Immunologic Marker,Laboratory Marker,Marker, Biochemical,Marker, Biological,Marker, Clinical,Marker, Immunologic,Marker, Laboratory,Marker, Serum,Marker, Surrogate,Serum Marker,Surrogate End Point,Surrogate End Points,Surrogate Endpoint,Surrogate Endpoints,Surrogate Marker,Viral Marker,Biological Marker,End Point, Surrogate,End Points, Surrogate,Endpoint, Surrogate,Endpoints, Surrogate,Marker, Biologic,Marker, Immune,Marker, Viral,Markers, Biologic,Markers, Immune
D034961 Antigens, Nuclear Immunologically detectable substances found in the CELL NUCLEUS. Extractable Nuclear Antigen,Nuclear Antigen,Nuclear Antigens,Extractable Nuclear Antigens,Antigen, Extractable Nuclear,Antigen, Nuclear,Antigens, Extractable Nuclear,Nuclear Antigen, Extractable,Nuclear Antigens, Extractable

Related Publications

B R Konety, and A K Nangia, and T S Nguyen, and B N Veitmeier, and R Dhir, and J S Acierno, and M J Becich, and R L Hrebinko, and R H Getzenberg
Characterization of nuclear matrix protein alterations associated with renal cell carcinoma.
June 2007, Urology,
B R Konety, and A K Nangia, and T S Nguyen, and B N Veitmeier, and R Dhir, and J S Acierno, and M J Becich, and R L Hrebinko, and R H Getzenberg
Identification of nuclear matrix protein alterations associated with human colon cancer.
April 2002, Cancer research,
B R Konety, and A K Nangia, and T S Nguyen, and B N Veitmeier, and R Dhir, and J S Acierno, and M J Becich, and R L Hrebinko, and R H Getzenberg
Identification of nuclear structural protein alterations associated with seminomas.
December 2009, Journal of cellular biochemistry,
B R Konety, and A K Nangia, and T S Nguyen, and B N Veitmeier, and R Dhir, and J S Acierno, and M J Becich, and R L Hrebinko, and R H Getzenberg
Urinary nuclear matrix protein 22 for diagnosis of renal cell carcinoma.
January 2005, Scandinavian journal of urology and nephrology,
B R Konety, and A K Nangia, and T S Nguyen, and B N Veitmeier, and R Dhir, and J S Acierno, and M J Becich, and R L Hrebinko, and R H Getzenberg
Nuclear matrix protein alterations associated with colon cancer metastasis to the liver.
October 2002, Clinical cancer research : an official journal of the American Association for Cancer Research,
B R Konety, and A K Nangia, and T S Nguyen, and B N Veitmeier, and R Dhir, and J S Acierno, and M J Becich, and R L Hrebinko, and R H Getzenberg
Identification of genomic alterations associated with metastasis and cancer specific survival in clear cell renal cell carcinoma.
November 2011, The Journal of urology,
B R Konety, and A K Nangia, and T S Nguyen, and B N Veitmeier, and R Dhir, and J S Acierno, and M J Becich, and R L Hrebinko, and R H Getzenberg
Nuclear matrix protein 2 antibody-positive dermatomyositis associated with hepatocellular carcinoma.
January 2023, Rheumatology advances in practice,
B R Konety, and A K Nangia, and T S Nguyen, and B N Veitmeier, and R Dhir, and J S Acierno, and M J Becich, and R L Hrebinko, and R H Getzenberg
Serological identification of antigens associated with renal cell carcinoma.
October 2002, Russian journal of immunology : RJI : official journal of Russian Society of Immunology,
B R Konety, and A K Nangia, and T S Nguyen, and B N Veitmeier, and R Dhir, and J S Acierno, and M J Becich, and R L Hrebinko, and R H Getzenberg
VHL protein alterations in sporadic renal cell carcinoma.
December 2007, Clinical oncology (Royal College of Radiologists (Great Britain)),
B R Konety, and A K Nangia, and T S Nguyen, and B N Veitmeier, and R Dhir, and J S Acierno, and M J Becich, and R L Hrebinko, and R H Getzenberg
Identification of a nuclear protein matrix.
October 1974, Biochemical and biophysical research communications,
Copied contents to your clipboard!